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Abstract
Type 1 polysaccharide storage myopathy caused by genetic mutation in the glycogen 
synthase 1 gene is present in many breeds including the Noriker and Haflinger horses. 
In humans, EMG has already been used to document changes in the muscle activity 
patterns of patients affected by human glycogen storage disorders. Therefore, the 
aim of the present study was to describe gluteus muscle activity with surface elec-
tromyography (sEMG) in Haflinger and Noriker horses with known GYS1 mutation 
status during walk and trot. Thirty- two horses (11 Haflinger and 21 Noriker horses) 
with homozygous non- affected (GG), heterozygous affected (GA) and homozygous 
affected (AA) status of GYS1 mutation without overt clinical signs of any myopathy 
were selected for the current study. Using surface electromyography gluteus medius 
muscle activity at walk and at trot was measured, and muscle activity was described 
in relation to the maximum observed value at the same sensor and the same gait. In 
order to further describe the signals in detail comprising both frequencies and ampli-
tudes, the crossings through the baseline and the 25, 50 and 75 percentile lines were 
determined. The result of the relative muscle activity did not show a consistent dif-
ference between affected and non- affected horses. Genetically affected (GA and AA) 
horses showed significantly less density of muscle activity for both gaits and horse 
breeds except for the crossings per second at the baseline and 75 percentile at walk 
in the Haflinger horses and 75 percentile at trot in the Noriker horses. The medians of 
all calculated density values were significantly lower in the GA Haflingers compared 
to the GG Haflingers (p = 0.012) and also in the AA Norikers compared to the GG 
Norikers (p = 0.011). Results indicate that the GYS1 mutation reduces the number 
of functional muscle fibres detected by sEMG measurements even in the absence of 
overt clinical signs.
K E Y W O R D S
Haflinger, muscle activity, Noriker, polysaccharide storage myopathy, surface 
electromyography
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1  |  INTRODUC TION
In the equine gluteus medius muscle (GM), regional fibre vari-
ations have been reported (Bruce & Turek, 1985; Grotmol et al., 
2002). For aerobic, slower, continuous work (e.g. for joint stabi-
lization) type I fibres are responsible for this activity; these are 
mostly found in the deeper layer of the muscle. For anaerobic, fast 
bursts of work such as joint movements during locomotion type 
II fibres are used, these are located in the superficial layer of the 
muscle. Such muscle functions can be affected by several equine 
disorders, such as myopathies creating dysfunctional muscle fibres 
(McCue et al., 2008). In horses, myopathies may be inherited (such 
as polysaccharide storage myopathy, PSSM) or acquired (such as 
rhabdomyolysis) (McCue et al., 2009). In humans, glycogen storage 
diseases of muscles also exist, and these are caused by mutations in 
genes controlling enzymes that metabolize glycogen and glucose. 
These human glycogen storage diseases are in some regards similar 
to equine PSSM, a muscular defect in horses, which is defined by 
the irregular build- up of the normal form of sugar stored in muscle 
(glycogen) as well as an irregular form of sugar (amylase- resistant 
polysaccharide) in muscle tissue (Valberg et al., 2011). Two types of 
PSSM are differentiated: type 1 PSSM is the form of PSSM caused 
by the genetic mutation in the glycogen synthase 1 gene (GYS1), 
while type 2 PSSM is characterized by abnormal polysaccharide in 
muscle biopsies without this GYS1 mutation (McCue et al., 2009). 
Type 1 PSSM is inherited as an autosomal dominant trait, and 
therefore, only one parent needs to pass it on, with a risk that off-
spring will develop the clinical disease.
The use of electromyography (EMG) is now widespread for 
the investigation of questions into equine movement and biome-
chanics (Kienapfel et al., 2017; St. George & Williams, 2013), and 
it has also been used to detect neurological deficits (Wijnberg 
et al., 2004). In humans, EMG has already been used to document 
changes in the muscle activity patterns of patients affected by 
human glycogen storage disorders (Bruno et al., 1993; Cornelio 
et al., 1984; Jeub et al., 2006). Specifically, abnormal electro-
myograms, described either as short duration and low amplitude 
motor unit potentials in the proximal muscles or decreased num-
ber of motor unit potentials in the proximal and distal muscles, 
were found in such patients (Cornelio et al., 1984), while in an-
other study positive sharp waves and fibrillation potentials were 
found to be associated with myopathy (Bruno et al., 1993). More 
recently, myopathic changes were found to be associated with 
pathological spontaneous EMG activity and pseudomyotonic dis-
charges (Jeub et al., 2006). Similar EMG changes might be pres-
ent in horses with PSSM type 1 mutation; however, the degree of 
clinical disease present with the PSSM1 mutation varies between 
breeds; probably as gene interactions, diet and exercise vary be-
tween individuals and between breeds (Pullman et al., 2000). Even 
horses without overt clinical signs of PSSM (such as muscle atro-
phy) show histological changes of muscle fibres, and they there-
fore may exhibit a different muscle activity pattern compared to 
horses without the PSSM1 mutation.
The aim of the present study was to compare the surface mus-
cle activity of the equine GM muscle in Haflinger and Noriker 
horses with known GYS1 mutation status during walk and trot. The 
following hypotheses were examined: (a) in both breeds, the sur-
face muscle activities show decreased activity in affected horses 
compared to non- affected horses and (b) the effect of GYS1 muta-
tion status is larger than the effect of breed on the muscle activity 
pattern.
2  |  MATERIAL S AND METHODS
2.1  |  Animals
Data were collected from two distinct subgroups, from 210 Noriker 
horses and from 14 Haflinger horses. All these horses were pre-
sented as healthy by their owners or handlers and had hair root 
samples taken from the tail or mane for DNA extraction and ge-
netic analyses and tested for GYS1 mutation. For the present study, 
7 Noriker triplets (GG, GA, AA) were selected (21 horses), as well 
as two similar groups of Haflingers (GG 6 horses, and GA 5 horses) 
based on the criteria sex, age, body mass. In the present study, meas-
urements obtained in two previous studies were used. A summary of 
the horses is shown in Table 1.
2.1.1  |  Noriker horses assessed in hand
Horses with homozygous non- affected (GG), heterozygous affected 
(GA) and homozygous affected (AA) status of GYS1 mutation were 
used. These horses were presented by the breeders or handlers and 
measured at walk and trot along a straight line of about 10 m. The 
study of Noriker horses was approved by the Commission for Ethics 
and Animal Welfare, University of Veterinary Medicine Vienna; pro-
tocol number and ETK- 20/06/2016.
TA B L E  1  Summary of horses used in the study
Noriker horses (n = 21)
Haflinger 




(n = 5) Mares (n = 11)
Age mean ± SD, 
years
7 ± 3 6 ± 5 7 ± 3
Body mass 
mean ± SD, kg









5 2 – 
Abbreviations: AA, homozygous affected; GA, heterozygous affected; 
GG, homozygous non- affected, SD, standard deviation.
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2.1.2  |  Haflinger horses assessed on the treadmill
Here, only horses with homozygous non- affected (GG) and het-
erozygous affected (GA) status of GYS1 mutation were used. These 
horses had been part of a previous study into the effect of feeding a 
carbohydrate- rich diet compared with hay- only diet muscle enzyme 
concentrations after treadmill exercise was studied (Schroeder et al., 
2015). Haflinger horses were handled by handlers known to them 
and measured at walk and at trot on a zero- per cent incline treadmill. 
They underwent a strict diet and exercise regime. For these horses, 
superficial muscle biopsies of GM were taken and histological tests 
were carried out. In these samples, no difference was found regard-
ing fibre size, fibre size variation and fibre type distribution with 
roughly 30% each of type I, type IIa and type IIb fibres found in both 
groups. Total myopathy score (including parameters such as angu-
loid atrophy, necrosis/macrophages and central nuclei) in affected 
horses was significantly higher than in control horses (p = 0.04) 
(Schroeder et al., 2015). The study of the Haflinger horses was ap-
proved by the institutional ethics committee of the University of 
Veterinary Medicine Vienna and the national authority according to 
§ 8ff of Law for Animal Experiments (Tierversuchsgesetz TVG, GZ 
68.205/0169- II/ 3 b/2012).
2.2  |  Data collection
All horses were measured at their natural speed three times 10 s 
both at walk and at trot, starting with all horses measured at walk, in 
order to allow the warm- up, followed by the trot measurements. A 
minimum of ten strides was used for further analysis.
2.2.1  |  Accelerometer and muscle activity 
measurements
Wireless surface electromyography (Delsys Trigno) sensors with 
in- built 3- axial accelerometers and wireless electrodes (each 
sensor consisting of four parallel metal bars with an integrated 
amplifier, size 27 × 37 × 15 mm, mass 14.7 g) were placed bilat-
erally and parallel to the fibre orientation over the left and right 
gluteus medius muscle. Due to the two different set- ups used in 
the studies from which the measurement were combined in the 
present study, the locations for sEMG electrodes were tested with 
(Noriker horses) and without (Haflinger horses) hair. In Noriker 
horses, the coat was thoroughly cleaned with a brush following 
by diligent dust removal with a textile towel, while in Haflinger 
horses the coat was shaved with a razor, and the skin was cleaned 
using isopropyl alcohol on slightly abrasive, roughly woven swabs. 
The exact position of the electrode was at the midpoint between 
origin and insertion in the middle of the widest section of the GM; 
this was identified by palpation of the tuber coxae, tuber sacrale 
and 3rd trochanter of the femur. The Delsys Adhesive Sensor 
Interface and additional adhesive tape were used to position the 
electrodes on the skin. After electrode placement, and prior to 
obtaining the sEMG measurements, the Delsys Real- time Signal 
Quality Monitor tool was used to check the signal quality and the 
presence of line interference for each electrode. At walk and at 
trot surface, electromyography (sEMG) at sampling frequency of 
2000 Hz collected the muscle activities and tri- axial acceleration 
(ACC) at sampling frequency of 148 Hz collected the accelerations 
from the hindlimbs.
2.3  |  Data processing
2.3.1  |  Accelerometer data processing
Three- dimensional (3D) sum acceleration of left and right gluteals 
were calculated. The acceleration data were resampled to 120 Hz, 
to fit it to the frequency of the resampled sEMG data. The con-
tinuous data were then segmented into motion cycles by cutting 
at the occurrence of the local minima of the 3D sum acceleration 
of the left and right hindlimbs, and sEMG data were cut accord-
ingly (Figure 1).
F I G U R E  1  The segmented gluteus 
medius muscle activity signal (green 
lines) of a Noriker horse shown with 
the crossings per seconds at trot (CS/s, 
i.e. the number of times the signal trace 
passes a defined value line) together with 
the accelerometer (ACC) curve of the 
hindlimb (black lines), vertical lines (purple 
lines) identifying the segmented motion 
cycles. A.u.: arbitrary unit. Trial length 
in seconds: represents the timeline of 
the measurements
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2.3.2  |  Surface electromyography signal processing
For all the data analysis, values are presented as calculated and in re-
lation to values of the healthy horses of the same breed (GG = 100%). 
This was done to allow comparison of data obtained in different 
measurement set- ups.
2.3.3  |  Arbitrary composite value
Additionally, the sEMG signal was reported as an arbitrary unit, 
with signals normalized to the range of sEMG values of each sen-
sor in each gait. A novel composite value reflecting the signal 
frequency at several signal amplitude was determined: incidents 
where the signal crosses a defined percentile value of the sEMG 
amplitude, either by exceeding it or by falling below it were ex-
pressed as crossings per second (CS/s), that is the frequency of 
the trace line passing a value in either direction (Figure 2). This 
newly established composite value is termed ‘density’ in the re-
mainder of the present paper. The density values were based 
on the sEMG data of each motion cycle and each sensor at the 
baseline (for CS/s@BL), the 25 percentile (for CS/s@25), the 50 
percentile (for CS/s@50) and the 75 percentile (for CS/s@75) 
(Figure 2).
2.3.4  |  Maximum muscle activity
After DC offset removal, high- pass filtering (5th order Butterworth 
filter with 40 Hz cut- off), full- wave rectification and resampling data 
were normalized to the maximum observed value of the muscle 
activity measured at each sensor and each gait and expressed as per 
cent (%MOA).
2.4  |  Statistical analysis
Statistical analyses were done in the statistical program R (Team, 
2013) using the MASS package (Venables & Ripley, 2002). Normality 
of distributions was tested with Shapiro– Wilk tests. For the group 
comparisons at each density level, non- parametric data were tested 
using a Kruskal– Wallis rank sum test and pairwise comparisons be-
tween group levels with Bonferroni corrections for multiple testing. 
Comparison of the medians of all density levels in each breed and ge-
netic group was carried out using Friedman's test with a Bonferroni 
correction for the Norikers (AA, GA, GG) and Wilcoxon signed- rank 
tests for the Haflingers (GA, GG). Pearson correlation coefficient 
was calculated to express correlations between muscle activities 
and GYS1 mutation status. In all of the tests above, the level of sig-
nificance was set at 0.05.
3  |  RESULTS
Comparing the results of data in relation to values of the healthy 
horses of the same breed (GG = 100%), for all horses and for both 
gaits the muscle activity densities (determined as described above) 
could be identified (Figures 3a– d and 4a– d). Based on the new com-
posite values in Noriker horses at walk and at trot and in Haflingers at 
trot, the genetically affected (GA and AA) horses had relative muscle 
activities below the genetically healthy (GG) horses (Figure 3b– d). 
Maximum muscle activity (%MOA) of Noriker horses at walk and of 
F I G U R E  2  One muscle activity segment selected from the trial of a Noriker horse to show a closer observation of the crossings. With 
the horizontal lines displayed over gluteus medius muscle activity the crossings (CS) at the baseline (CS/s@BL) was 99, the crossings at the 
25 percentile (CS/s@25) was 91, the crossings at the 50 percentile (CS/s@50) and the crossings at the 75 percentile (CS/s@75) was 90. 
Please note that baseline (CS/s@BL) and the crossings at the 50 percentile (CS/s@50) very close. A.u.: arbitrary unit. Trial length in seconds: 
represents the timeline of the measurements
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Haflingers at walk and trot showed the genetically affected (GA and 
AA) horses to have a relative muscle activity below the genetically 
healthy (GG) horses (Figure 4a– c). For both methods, no statistical 
tests were carried out, as they were only used for normalization pur-
poses to allow the data to be compare between the two different 
measurement set- ups.
F I G U R E  3  Homozygous non- affected horses considered as 100%. Relative muscle activity of the affected horses is shown as normalized 
to the CS/s of non- affected horses of the same breed at BL, at 25%, 50% and 75% at walk and trot respectively. AA, homozygous affected; 
GA, heterozygous affected; and GG, homozygous non- affected
F I G U R E  4  Homozygous non- affected horses considered as 100%. Relative muscle activity of the affected horses is shown as 
normalized to the %MOE of non- affected horses of the same breed at walk and trot respectively. GG: homozygous non- affected, GA: 
heterozygous affected, AA: homozygous affected, maximum observed value of the muscle activity (%MOA)
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The median values of the muscle activity densities for CS/s@
BL ranged 34– 51 with IQRs 30– 60 in Noriker horses and 12– 16 
with IQRs 10– 16 in Haflinger horses. The median values of the 
muscle activity densities for CS/s@25 ranged 24– 39 with IQRs 
21– 44 in Noriker horses and 4– 11 with IQRs 2– 13 in Haflinger 
horses. The median values of the muscle activity densities for 
CS/s@50 ranged 32– 50 with IQRs 25– 60 in Noriker horses 
and 8– 16 with IQRs 4– 16 in Haflinger horses. The median val-
ues of the muscle activity densities for CS/s@75 ranged 24– 41 
with IQRs 23– 47 in Noriker horses and 9– 12 with IQRs 5– 14 in 
Haflinger horses (Tables 2 and 3).
The median values of the %MOA for 6– 10, with IQRs 4– 14 in 
Norikers at walk and 11– 13 with IQRs 10– 15 in Haflingers at walk. 
The median values of the %MOA for 12– 16, with IQRs 8– 19 in 
Norikers at trot and 12– 13 with IQRs 10– 15 in Haflingers at trot 
(Tables 2 and 3).
The statistical test results of pairwise comparisons between 
group levels with corrections for multiple testing found the muscle 
activity densities for CS/s@50 in Haflingers at trot between the dif-
ferent groups of GYS1 mutation status were found to be significant 
(p < 0.04) (Table 2). In Noriker horses, test results of pairwise com-
parisons between group levels with corrections for multiple testing 
found the muscle activity densities for CS/s@25 at walk were signifi-
cantly different between the GG and GA (p < 0.04) (Table 3).
Comparison of the medians of all density levels in Norikers 
showed significant differences between the GG and AA (p = 0.011) 
and in Haflingers between the GG and GA (p = 0.012) (Table 3).
Pearson correlation coefficient showed significant correla-
tions with healthier having higher values in CS/s@BL (r = −0.52), in 
CS/s@25 (r = −0.46) and in CS/s@50 (r = −0.48) at walk in the Noriker 
horses (p < 0.05) and in CS/s@50 (r = −0.67) at trot in the Haflinger 
horses (p < 0.04).
The distribution of density of muscle activity in Haflinger and 
Noriker horses was very similar within the status of GYS1 muta-
tion; however, the Haflingers showed lower values throughout 
TA B L E  2  Median and interquartile ranges of gluteus medius 
muscle activity of Haflinger horses walking and trotting on the 
treadmill
Haflinger horses
GG (n = 6) GA (n = 5)
Median IQR Median IQR
WALK CS/s@BL 15 13– 16 13 11– 15
TROT CS/s@BL 16 15– 16 12 10– 15
WALK CS/s@25 9 7– 10 4 2– 6
TROT CS/s@25 11 11– 13 9 7– 9
WALK CS/s@50 15 13– 16 8 4– 11
TROT CS/s@50 16* 15– 16 10* (p = 0.032) 6– 12
WALK CS/s@75 10 9– 12 9 7– 12
TROT CS/s@75 12 11– 13 9 5– 14
WALK %MOA 13 10– 15 11 11– 12




GG <> GA p = 0.012
Note: The crossings at the baseline per seconds (CS/s@BL), the 
crossings at the 25 percentile per seconds (CS/s@25), the crossings 
at the 50 percentile per seconds (CS/s@50) and the crossings at the 
75 percentile per seconds (CS/s@75) and the relative to maximum 
observed activity (%MOA). Asterisks (*) indicate significant differences 
between these two values.
Abbreviations: AA, homozygous affected; GA, heterozygous affected; 
GG, homozygous non- affected, SD, standard deviation.
Noriker horses
GG (n = 7) GA (n = 7) AA (n = 7)
Median IQR Median IQR Median IQR
WALK CS/s@BL 45 39– 52 34 32– 36 35 30– 37
TROT CS/s@BL 50 45– 60 51 40– 56 40 38– 53
WALK CS/s@25 37* 29– 39 24* p = 0.037 21– 26 27 24– 30
TROT CS/s@25 39 33– 44 33 29– 39 28 27– 37
WALK CS/s@50 42 38– 48 32 25– 34 29 28– 32
TROT CS/s@50 50 44– 60 49 37– 55 39 31– 54
WALK CS/s@75 29 26– 33 24 23– 27 24 26– 26
TROT CS/s@75 41 30– 47 34 30– 44 34 30– 47
WALK %MOA 10 7– 14 6 4– 7 6 4– 8
TROT %MOA 10 8– 12 12 8– 13 16 11– 19
Overall CS/s median comparisons GG <> AA p = 0.011
Note: The crossings at the baseline per seconds (CS/s@BL), the crossings at the 25 percentile per 
seconds (CS/s@25), the crossings at the 50 percentile per seconds (CS/s@50) and the crossings at 
the 75 percentile per seconds (CS/s@75) and the relative to maximum observed activity (%MOA). 
Asterisks (*) indicate significant differences between these two values.
Abbreviations: AA, homozygous affected; GA, heterozygous affected; GG, homozygous non- 
affected, SD, standard deviation.
TA B L E  3  Median and interquartile 
ranges of gluteus medius muscle activity 
of Noriker horses walking and trotting in 
hand
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(Figure 5a– d), while the %MOA did not show the genetic difference 
(Figure 5e).
4  |  DISCUSSION
In the present study, data were analysed using two different ap-
proaches, a more traditional analysis documenting the relationship 
between the maximum observed values measured at each sensor 
in each gait, which is recommended for normalization (St. George 
et al., 2019; Zsoldos et al., 2014). This did not show a consistent and 
convincing difference between affected and non- affected horses. 
However, based on the histology of PSSM and the reduced number 
of functional muscle fibres (Schroeder et al., 2015), in the present 
paper a novel analysis of the sEMG data was applied. With this, 
we could show that throughout the locomotion the density of the 
gluteus medius muscle activity is higher in the majority of the non- 
affected horses than in the genetically affected horses; this is true 
for both walk and trot. Higher values were found for the affected 
horses for the baseline and for the 75 percentile values at walk in 
Haflingers and for the 75 percentile values at trot in Noriker horses. 
The reason for this may be that even in the absence of overt clinical 
signs of PSSM, such as muscle atrophy, subtle histology signs of myo-
pathy were seen in the GA Haflingers and Norikers, as the myopathy 
score was significantly higher than in the GG Haflingers (Schroeder 
et al., 2015). Thus, the mutation seems to lead to a reduction in func-
tional muscle fibres available for the measurement with sEMG.
The electrical activity of the muscle may also be influenced by 
the fibre types sampled by the electrodes used; however, this is still 
under investigation. The Haflingers used in the present study did 
not show differences in their fibre types on biopsy of the gluteus 
muscle. Also, the depth of the area sampled by sEMG measurement 
is not clearly defined, and therefore, the difference in fibre types 
between more superficial and deeper areas of the gluteus muscle 
(Payne et al., 2005) may have been influential, that should be docu-
mented in future using intramuscular EMG readings.
In the different draft horse breeds all across Europe and North 
America, type 1 PSSM I is present (Baird et al., 2010). Allele age esti-
mations indicating that the underlying GYS1 mutation with the GYS1 
Arg309His allele originated 1200– 1500 years ago, and many draft 
horse breeds today were derived from these horses (McCue et al., 
2008, Valentine et al., 1999). This is continued to be preserved in 
many breeds of the domestic horse (McCoy et al., 2014). In the rela-
tively old Austrian Noriker breed and in other older European horse 
F I G U R E  5  Distribution of density of muscle activity in Haflinger and Noriker horses with GYS1 mutation status of homozygous non- 
affected (GG), heterozygous affected (GA) and homozygous affected (AA). Each (non- normalized) value collected both at walk and at trot is 
represented as a single dot. (a) Crossings at the baseline per seconds (CS/s@BL), (b) the crossings at the 25 percentile per seconds (CS/s@25), 
(c) the crossings at the 50 percentile per seconds (CS/s@50) and (d) the crossings at the 75 percentile per seconds (CS/s@75) and (e) the 
relative to maximum observed activity (%MOA)
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breeds (Belgian Draft and South German Coldblood), the GYS1 
Arg309His allele is present, and a significant percentage of founder 
mares of the Haflinger breed are thought to have been Norikers 
(Druml et al., 2017, 2008).
The large influence of diet and exercise on the clinical disease 
of type 1 PSSM has been documented (Baird et al., 2010). In the 
Haflingers in the present study, management factors such as diet 
and exercise were strictly controlled, while in the Norikers a large 
variety of environmental factors were present as neither diet nor 
exercise had been standardized. Despite these differences, the ef-
fect of the GYS1 mutation on the sEMG measurements was similar 
in both breeds.
In humans, a glycogen debrancher enzyme deficiency disease ex-
ists (Cori disease, also known as glycogen storage disease type III). 
Cornelio et al. (1984) showed in two patients with clinically apparent 
debrancher deficiency that the EMG profile included short duration 
and low amplitude motor unit potentials in their proximal muscles 
and that the motor unit potentials were increased in duration and 
amplitude in the first dorsal interosseus of the hands and in the tibi-
alis anterior. Such an increased duration of motor unit potentials (i.e. 
reduced frequency of motor unit potentials) corresponds well with 
the decreased muscle activity density, also reflecting reduced mus-
cle activity frequency, found in the horses with GYS1 mutation in the 
present study. In the aforementioned study, there were also abun-
dant fibrillations in every muscle tested, and the number of motor 
unit potentials was decreased (Cornelio et al., 1984).
For the present study, Noriker and Haflinger horses were se-
lected with similar age ranges and body mass to decrease the body 
size differences between the two breeds. In the Noriker breed, 
triplets of horses (AA, GA, GG) could be identified, which is ideal. 
Unfortunately, this was not possible in the Haflinger horses, where 
all horses were mares, but ages and body masses did not allow such 
an exact pairing of individuals, therefore they were analysed as rea-
sonably homogenous groups.
The matching for the age of the animals was especially import-
ant, as muscle fibres are still developing in young individuals, leading 
to MUPs of shorter duration and lower amplitude than in adult or 
older horses (Wijnberg et al., 2003), which should not be misinter-
preted as myopathy. With ageing, the muscle starts to degenerate 
mildly, resulting in larger, broader MUPs, which again should not be 
mistaken for mild neuropathy (Wijnberg et al., 2003).
The measurements of the Noriker horses were carried out 
over ground, while the measurements of the Haflinger horses 
were carried out on the treadmill and in both cases the results 
were time normalized. It is well known in the equine biomechan-
ics field that there are major differences to study muscle function 
over ground or on the treadmill (Buchner et al., 1994), one of the 
main functional difference could be that the GM muscle function 
during locomotion is less forceful on the treadmill compared to 
over ground. Despite these obvious differences in the muscle use 
required, the present study showed that the muscle results did not 
differ between the Noriker and Haflinger horses, indicating the 
stability of the method.
5  |  CONCLUSIONS
Muscle activity relative to the maximum observed value does not 
show consistent differences between horses with and without 
mutation in the glycogen synthase 1 gene (GYS1). Using this novel 
method, the arbitrary composite value of muscle density, such 
differences can be shown. Specifically, the reduced frequency 
and reduced amplitude present in the horses with the mutation 
potentially reflect a reduced number of muscle fibres sampled by 
each sEMG sensor, even in the absence of overt clinical signs. We 
believe that this shows the potential of using surface electromy-
ography to document myopathy even without overt clinical signs.
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